
    
      This is a single arm prospective study of 18 weeks aimed to evaluate the safety and
      efficiency of Silk'n HST treatment on the periorbital areas. 30 subjects will be enrolled by
      a single USA clinical site. Throughout the trial there will be 3 pre-scheduled face to face
      treatment visits, as well as additional 18 independent treatments at home. 2 additional
      follow-up visits will be conducted 1 and 3 months following treatment end. In addition, 2
      maintenance treatment will be conducted independently at home once a month following
      treatment end.
    
  